Amphastar Pharmaceuticals (AMPH) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 1, 2026, with virtual participation available to shareholders.

• Shareholders are encouraged to review proxy materials and vote by May 31, 2026.

Voting matters and shareholder proposals

• Election of three Class I directors to serve until the 2029 annual meeting: David Gaugh, William J. Peters, and Jacob Liawatidewi.

• Ratification of Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2026.

• Advisory vote to approve named executive officer compensation.

• Advisory vote on the frequency of future say-on-pay votes, with a recommendation for annual votes.

• Provision to transact other business as may properly come before the meeting.

Board of directors and corporate governance

• Board recommends all director nominees and proposals for shareholder approval.